Passage Bio (PASG): 10% owner bought ~$379K
Lynx1 Capital Management LP, 10% owner at Passage Bio, bought ~$379K of Passage Bio shares.
- ~$379K
- Approx. value · 66K sh @ $5.71
- 592K
- Holds after · shares reported
- Traded
- Jul 24, 2025
- Filed
- Jul 24, 2025
What stands out in this filing
- After this purchase the filing reports 591,696 shares, held indirectly.
- 66,423 shares at an average of $5.71 each, as reported on the form.
- The first open-market purchase by this insider in 0 months.
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jun 24, 2025Insider10% owner sold ~$81K of PASG shares in the open market
- Jun 25, 2025Insider10% owner sold ~$46K of PASG shares in the open market
- Jun 26, 2025Insider10% owner sold ~$70K of PASG shares in the open market
- Jul 22, 2025Insider10% owner purchased ~$71K of PASG shares in the open market
- Jul 23, 2025Insider10% owner purchased ~$283K of PASG shares in the open market
- Jul 24, 2025 · this disclosureInsider10% owner purchased ~$379K of PASG shares in the open market
What came next
- Sep 11, 2025Insider · 5 days before an 8-K10% owner purchased ~$2.3K of PASG shares in the open market
- Sep 12, 2025Insider · 4 days before an 8-K10% owner purchased ~$138K of PASG shares in the open market
- Sep 15, 2025Insider · 1 day before an 8-K10% owner purchased ~$83K of PASG shares in the open market
- Sep 16, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 16, 2025, Saqib Islam notified Passage Bio, Inc. (the “ Company ”) of his decision to resign from the Company’s Board of Directors (the “ Board ”), including from the Audit Committee of the Board (the “ Audit Committee ”), effective immediately (the “ Resignation Date ”).”
- Nov 10, 2025Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Passage Bio
OQRO holds no insider, Congress, fund or contract record for Passage Bio dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PASG page.
Other recent filings by Lynx1 Capital Management LP, 10% owner
- SEC Form 4 at Korro Bio (KRRO)Oct 26, 2026
- SEC Form 4 at Korro Bio (KRRO)Oct 26, 2026
- SEC Form 4 at Korro Bio (KRRO)Oct 26, 2026
- SEC Form 4 at Korro Bio (KRRO)Oct 26, 2026
- SEC Form 4 at Passage Bio (PASG)Jun 30, 2026
The full history of Lynx1 Capital Management LP, 10% owner is on the profile page.
How this filing works
Explore the data
Common questions
Which Passage Bio (PASG) insider traded, and how much?
Lynx1 Capital Management LP, 10% owner at Passage Bio, bought ~$379K of Passage Bio shares. 66K shares at $5.71, open market.
When did it happen, and when was it made public?
Traded: Jul 24, 2025. Filed: Jul 24, 2025.
What stands out in this filing?
After this purchase the filing reports 591,696 shares, held indirectly. 66,423 shares at an average of $5.71 each, as reported on the form. The first open-market purchase by this insider in 0 months.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
Does this mean PASG stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Passage Bio
- SEC Form 4Jun 30, 2026
- SEC Form 4Jan 13, 2026
- SEC Form 4Jan 13, 2026
- SEC Form 4Sep 16, 2025
- SEC Form 4Sep 16, 2025
- SEC Form 4Sep 16, 2025
Everything OQRO holds on this company is on its PASG page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data